Welcome to BioMarket Group!

Electronic Sampling: Influencing Physician Prescribing Behavior Through More Efficient Sampling Approaches

Additional Information

Published Date Aug 6, 2004
Special Offer No
Pages 56
PDF Fact Sheet View Fact Sheet for the report Electronic Sampling: Influencing Physician Prescribing Behavior Through More Efficient Sampling Approaches in PDF format.
Published on Date No
Format No
Publisher Datamonitor
Product Line No
Full Title Electronic Sampling: Influencing Physician Prescribing Behavior Through More Efficient Sampling Approaches

Availability: In stock

$3,800.00

Quick Overview

Electronic sampling, used in combination with in-person sampling initiatives, has the potential to increase ROI by cost-effectively expanding sample distribution. Pharmaceutical companies looking to adopt electronic sampling solutions should choose a vendor that is able to demonstrate stability, as well as offer a non-disruptive link between established sample distribution sites and physicians.
Request free sample pages from Electronic Sampling: Influencing Physician Prescribing Behavior Through More Efficient Sampling Approaches

Introduction

Electronic sampling, used in combination with in-person sampling initiatives, has the potential to increase ROI by cost-effectively expanding sample distribution. Pharmaceutical companies looking to adopt electronic sampling solutions should choose a vendor that is able to demonstrate stability, as well as offer a non-disruptive link between established sample distribution sites and physicians.

Scope

  • Analyzes the growing electronic sampling market in the US and Europe, including general strategies for assessing eSampling vendors
  • Defines characteristics of electronic sampling vendors that are important to long-term stability in the market
  • Explores challenges companies will face when designing an integrated electronic sampling solution
  • Looks at current industry leaders operating within the eSampling market, including their best practices and opportunities for improvement

Highlights

The current vendor market is immature and highly in flux. The past few months has seen the dissolution of a handful of eSampling platforms and their providers. At the same time, other vendors are just beginning to develop solutions and move into the market. Companies interested in eSampling should carefully consider the stability of their vendor.

Traditionally, despite having the decisive function in distributing drug samples to patients, prescribers have had little or no control over what samples they received and when. By more accurately matching the supply of samples with demand, the pharmaceutical industry has an opportunity to increase sales and more efficiently distribute resources.

Patients, in particular, will help drive the expansion of the eSampling market in the US as they begin to play a larger role in the prescribing process by requesting specific treatments based on information gained online.

Reasons to Purchase

  • Understand the current and prospective electronic sampling opportunities in both the US and European pharmaceutical markets
  • Recognize how to effectively target electronic sampling services to best serve the needs of both physicians and consumers
  • Understand the limitations and opportunities offered by each eSampling approach and hasten adoption by choosing the best vendor for your company
Request free sample pages from Electronic Sampling: Influencing Physician Prescribing Behavior Through More Efficient Sampling Approaches

Other selected research from the 'Healthcare' category:


Neuropathic Pain: Emerging Drugs and Current Treatment Practices
This report presents a comprehensive update on emerging drug candidates for neuropathic pain, (NP) together with the findings of global survey on current treatment practices in the clinic, following the... Learn More


US Preterm Infant Care Market
Neonatal (Preterm) infant care forms a significant part of the pediatric healthcare market in the U.S. as Neonatal (Preterm) births are one of the leading causes of infant mortality in... Learn More

Other selected research from the 'Pharmacoeconomics' category:


The Pharmaceutical CRM Outlook: Optimizing returns from operational and analytical CRM
Report which analyzes the current operational and analytical CRM practises and outlines in detail future developments that will increase the return on investment (ROI) within sales, marketing and customer fulfilment activities. Learn More


Insomnia - Wake-Up Call for a Sleepy Market
Approximately 50% of the population experience symptoms of insomnia on a regular basis. However, only a fraction of patients are diagnosed, with even fewer receiving prescribed pharmacological therapy. Currently Sanofi`s Ambien (zolpidem) is the market leader across the seven major markets, with revenues of $1.7 billion in 2003. Learn More